Nastorazepide
Product Specifications
CAS Number
209219-38-5
Target
HIF/HIF Prolyl-Hydroxylase, Ephrin Receptor, VEGFR, Akt, Cholecystokinin Receptor, Interleukin
Related Pathways
Cytoskeletal Signaling, Metabolism, GPCR/G Protein, Tyrosine Kinase/Adaptors, PI3K/Akt/mTOR signaling, Angiogenesis, Immunology/Inflammation, Chromatin/Epigenetic
Purity
0.9983
Bioactivity
Nastorazepide (Z-360) is a selective, orally available antagonist of the gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
Smiles
CC(C)(C)C(=O)CN1c2ccccc2N(C[C@@H](NC(=O)Nc2cccc(c2)C(O)=O)C1=O)C1CCCCC1
Molecular Formula
C29H36N4O5
Molecular Weight
520.62
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
037755-AP 200 µL
LGMN, NT (LGMN, PRSC1, Legumain, Asparaginyl endopeptidase, Protease, cysteine 1) (AP) discontinued
Sign In for Pricing
View Details 
LS054606-100ug 100 µg
DDX56 (NM_019082) Human Over-expression Lysate
Sign In for Pricing
View Details